AKBM — Aker Biomarine ASA Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMid CapNeutral

Annual income statement for Aker Biomarine ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	Interim Report
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	289	262	277	335	199
Cost of Revenue
Gross Profit	110	88.1	115	113	78.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	282	276	255	330	203
Operating Profit	7	-13.7	22.1	5.3	-4.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.688	-7.4	12.2	-33.9	-12.1
Provision for Income Taxes
Net Income After Taxes	-5.46	-8.01	10	-8.9	-12.2
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-5.46	-8.01	10	-8.9	182
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-5.46	-8.01	10	-9	183
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.154	-0.044	0.156	-0.014	-0.04
Dividends per Share